| abstract |
For the treatment of pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, as well as structural damage to tissues caused by inflammatory diseases, such as joint tissue and / or caused by osteoarthritis or rheumatoid arthritis Alternatively, a corticosteroid microparticle formulation is provided for use to slow, stop or improve damage to periarticular tissue. Corticosteroid microparticulates as topical release dosage forms (with or without immediate release components) that provide efficacy with no clinically problematic or measurable effects on endogenous cortisol production Administer. |